Segment Disclosures and Concentrations of Risk (Tables)

3 Months Ended

Mar. 31, 2020

Segment Reporting [Abstract]

Schedule of Reported Segment Revenues and Profit or Loss, and Reconciliation

The following table presents information about reported segment revenues and profit or loss, as well as a reconciliation of each such amount to consolidated totals:

(In thousands)
	Three Months Ended March 31, 2020								Three Months Ended March 31, 2019
	Healthcare		Nutrition			Total Segments			Healthcare		Nutrition		Total Segments
Revenues	$	159,692	$	177,963		$	337,655		$	156,527	$	57,567	$	214,094	(1)
Consolidated income (loss) before income taxes						$	(213,252	)					$	9,582
Acquisition and integration costs							2,791							17,052
Impairment loss							199,500							—
CEO transition costs							2,586							—
Restructuring and related charges							742							1,591
Interest expense							21,664							7,666
Depreciation and amortization							14,763							3,582
Adjusted EBITDA	$	30,242	$	(1,448	)	$	28,794		$	26,129	$	13,344	$	39,473

(1) The figure for total segments equals the consolidated figure for such item.

Schedule of Total Assets by Segment

Our total assets by segment were as follows:

(In thousands)	March 31, 2020		December 31, 2019
Healthcare	$	563,027	$	526,013
Nutrition		905,256		1,099,892
Total assets	$	1,468,283	$	1,625,905